Live Status Check

NCT06699901 Recruiting Status

Real-time enrollment status for this adverse effects in the therapeutic use of other and unspecified agents affecting blood constituents clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 3:03 PM UTC

NCT06699901 Status Summary

NCT NumberNCT06699901
Recruiting StatusRecruiting
ConditionAdverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents
PhaseClinical Trial
Target Enrollment417 participants
Active Locations2 sites in the US
SponsorBrooke Army Medical Center
Last Updated on CT.govFebruary 11, 2025 (Feb 11, 2025)

About NCT06699901 Enrollment Status

As of July 13, 2026: Clinical trial NCT06699901 is currently recruiting participants. This clinical trial study for adverse effects in the therapeutic use of other and unspecified agents affecting blood constituents is actively seeking new participants at 2 locations across the United States. The study is sponsored by Brooke Army Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06699901

Is NCT06699901 still recruiting?

Yes, NCT06699901 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06699901 recruiting?

This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06699901?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06699901 status last updated?

The official ClinicalTrials.gov record for NCT06699901 was last updated Feb 11, 2025 (February 11, 2025). HelloStudys verifies this status automatically.

Browse More Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents Trials

Ready to Apply?

Check your eligibility for this clinical trial